[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.]

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Abstract Text:

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Publishing Authors By Initials

For similar heterocyclic compounds: alkaloids: indole alkaloids: secologanin tryptamine alkaloids: vinca alkaloids: vinblastine research abstracts see: heterocyclic compounds: alkaloids: indole alkaloids: secologanin tryptamine alkaloids: vinca alkaloids: vinblastine research

PUBMED ID PMID:

MEDLINE DATE:

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Folia haematologica; internationales Magazin für B

VOLUME: 7

Page Numbers: 22-4

Journal Abbreviation:

ISSN: 0015-556X

DAY: 22

MONTH: Apr

YEAR: 1963

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 140243

[Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Keywords Mesh Terms:

KEYWORDS: Vinblastine

MESH TERMS:

Chemical & Substance for Abstract: [Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.] Information

Substance Name: Vinblastine

Registry Number: 865-21-4

Grant and Affiliation Information for [Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.]

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Folia Haematol (Frankf)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Vinca rosea in the treatment of hemoblastoses and similar clinical pictures Related Publications

• Beta1 integrin expression pattern in transitional urothelium does not allow for efficient stem cell enrichment as in other epithelia.
• Complete bladder duplication presenting as incontinence in an 11-year-old girl.
• Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.
• Cutaneous castleman's disease responds to anti interleukin-6 treatment.
• Development and validation of the fecal incontinence and constipation quality of life measure in children with spina bifida.
• Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials.
• How do we measure hypospadias outcomes?
• Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.
• Interleukin-6 and its receptor in cancer: implications for Translational Therapeutics.
• Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib.
• Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.
• Non-surgical management of multicystic dysplastic kidney.
• Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies.
• Short stay pyeloplasty: variables affecting pain and length of stay.
• Studies in target-based treatment.
• The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
• [Vinca rosea in the treatment of hemoblastoses and similar clinical pictures.]